EX-24.1 9 d438975dex241.htm EX-24.1 EX-24.1

EXHIBIT 24.1

POWER OF ATTORNEY

Each of the undersigned does hereby appoint GERALYN S. RITTER and BRUCE N. KUHLIK and each of them, severally, his/her true and lawful attorney or attorneys to execute on behalf of the undersigned (whether on behalf of the Company, or as an officer or director thereof, or by attesting the seal of the Company, or otherwise) the Form 10-K Annual Report of Merck & Co., Inc. for the fiscal year ended December 31, 2012 under the Securities Exchange Act of 1934, including amendments thereto and all exhibits and other documents in connection therewith.

IN WITNESS WHEREOF, this instrument has been duly executed as of the 28th day of February 2013.

 

MERCK & CO., INC.   

/s/ Kenneth C. Frazier

        Kenneth C. Frazier

  

Chairman, President and Chief Executive Officer

(Principal Executive Officer; Director)

/s/ Peter N. Kellogg

        Peter N. Kellogg

  

Executive Vice President and Chief Financial Officer

(Principal Financial Officer)

/s/ John Canan

        John Canan

  

Senior Vice President Finance—Global Controller

(Principal Accounting Officer)

  

DIRECTORS

 

/s/ Leslie A. Brun      

/s/ Carlos E. Represas

   
        Leslie A. Brun             Carlos E. Represas  
/s/ Thomas R. Cech      

/s/ Patricia F. Russo

   
        Thomas R. Cech             Patricia F. Russo  
/s/ Thomas H. Glocer    

/s/ Craig B. Thompson

 
        Thomas H. Glocer             Craig B. Thompson  
/s/ William B. Harrison, Jr.    

/s/ Wendell P. Weeks

 
        William B. Harrison, Jr.             Wendell P. Weeks  
/s/ C. Robert Kidder    

/s/ Peter C. Wendell

 
        C. Robert Kidder             Peter C. Wendell  
/s/ Rochelle B. Lazarus      
        Rochelle B. Lazarus